26 research outputs found
Selected nondigestible carbohydrates and prebiotics support the growth of probiotic fish bacteria mono-cultures in vitro
To search for nondigestible but fermentable (NDF) carbohydrates and prebiotics with a potency to promote the growth of selected bacteria in vitro.
The growth of three reference bacteria strains Bacillus subtilis LMG 7135(T), Carnobacterium piscicola LMG 9839, Lactobacillus plantarum LMG 9211 and one candidate probiotic bacteria Lactobacillus delbrueckii subsp. lactis was investigated over a minimum period of 48 h in the presence of beta-glucan, xylo-oligosaccharide, arabinoxylo-oligosaccharide, inulin, oligofructose and glucose. Besides the capability to grow on inulin and oligofructose containing media, a distinct high growth in beta-glucan based substrates and a low growth in (arabino)xylooligosaccharide containing media were evident for most bacteria tested. With the exception of B. subtilis and L. plantarum, other bacteria grew equally well or even better on different substrates than on glucose. The fermentation of studied carbohydrates by these micro-organisms was dominated by the production of acetic acid as the main short chain fatty acid.
Selected bacteria are able to ferment and grow on NDF and prebiotic carbohydrates but in a substrate dependent manner.
This study delivers a first screening of which NDF or prebiotic carbohydrates are the most promising for aquaculture feed supplementations
Recommended from our members
Comparative prebiotic activity of mixtures of cereal grain polysaccharides
The main components of the non-starch polysaccharide (NSP) fraction of wheat flour are arabinoxylan (AX) and β-glucan. These are also present in other cereal grains, but their proportions vary with AX being the major component in wheat and rye and β-glucan in barley and oats. Therefore, it was hypothesised that these NSPs could act synergistically when fermented in vitro at the ratios present in the major foods consumed, resulting in increased prebiotic activity. AX and β-glucan were therefore tested in in vitro fermentation studies to assess their prebiotic activity when used individually and/or in different ratios. Short-chain fatty-acids (SCFAs) produced from in vitro fermentation were measured using HPLC and bacterial populations were measured using flow cytometry with fluorescence in situ hybridisation (Flow-FISH). Fermentation of AX alone resulted in a significant bifidogenic activity and increased concentrations of SCFAs, mainly acetate, after 8-24 h of fermentation, however β-glucan alone did not show prebiotic activity. The greatest prebiotic activity, based on concentration of total SCFAs and increases in total bacteria as well as beneficial Bifidobacterium and Clostridium coccoides/Eubacterium groups, was observed when AX and β-glucan were combined at a 3:1 ratio, which corresponds to their ratios in wheat flour which is major source of cereal fibre in the diet. This indicates that the population of bacteria in the human GI tract may be modulated by the composition of the fibre in the diet, to maximise the prebiotic potential
Application of tailor-made membranes in a multi-stage process for the purification of sweeteners from Stevia rebaudiana
In this paper the performance of a three stage process with commercial as well as tailor-made polyether-sulphone (PES) membranes for the purification of sweeteners from Stevia rebaudiana Bertoni was evaluated. Retentions of the sweeteners for a synthetic mixture and plant extract in combination with flux decline measurements indicated that, in contrast with the lab-made membranes, on most commercial membranes a foulant layer was formed that influenced the separation performance negatively. For the plant extract, the best commercial membrane (PW010) had a selectivity and flux similar to the best lab-made membrane (27% PES), but the lab-made membrane was preferred because it showed a slightly lower retention of the sweeteners, as desired. Starting from an extract purity of 11% with the overall process (microfiltration, ultrafiltration, nanofiltration) a purity of 37% and a yield of 30% could be reached. (C) 2010 Elsevier Ltd. All rights reserved.status: publishe
Application of tailor-made membranes in a multi-stage process for the purification of sweeteners from Stevia rebaudiana.
a b s t r a c t In this paper the performance of a three stage process with commercial as well as tailor-made polyethersulphone (PES) membranes for the purification of sweeteners from Stevia rebaudiana Bertoni was evaluated. Retentions of the sweeteners for a synthetic mixture and plant extract in combination with flux decline measurements indicated that, in contrast with the lab-made membranes, on most commercial membranes a foulant layer was formed that influenced the separation performance negatively. For the plant extract, the best commercial membrane (PW010) had a selectivity and flux similar to the best lab-made membrane (27% PES), but the lab-made membrane was preferred because it showed a slightly lower retention of the sweeteners, as desired. Starting from an extract purity of 11% with the overall process (microfiltration, ultrafiltration, nanofiltration) a purity of 37% and a yield of 30% could be reached
Recommended from our members
A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylanoligosaccharides enriched bread in healthy volunteers
BACKGROUND:
Prebiotics are food ingredients, usually non-digestible oligosaccharides, that are selectively fermented by populations of beneficial gut bacteria. Endoxylanases, altering the naturally present cereal arabinoxylans, are commonly used in the bread industry to improve dough and bread characteristics. Recently, an in situ method has been developed to produce arabinoxylan-oligosaccharides (AXOS) at high levels in breads through the use of a thermophilic endoxylanase. AXOS have demonstrated potentially prebiotic properties in that they have been observed to lead to beneficial shifts in the microbiota in vitro and in murine, poultry and human studies.
METHODS:
A double-blind, placebo controlled human intervention study was undertaken with 40 healthy adult volunteers to assess the impact of consumption of breads with in situ produced AXOS (containing 2.2 g AXOS) compared to non-endoxylanase treated breads. Volatile fatty acid concentrations in faeces were assessed and fluorescence in situ hybridisation was used to assess changes in gut microbial groups. Secretory immunoglobulin A (sIgA) levels in saliva were also measured.
RESULTS:
Consumption of AXOS-enriched breads led to increased faecal butyrate and a trend for reduced iso-valerate and fatty acids associated with protein fermentation. Faecal levels of bifidobacteria increased following initial control breads and remained elevated throughout the study. Lactobacilli levels were elevated following both placebo and AXOS-breads. No changes in salivary secretory IgA levels were observed during the study. Furthermore, no adverse effects on gastrointestinal symptoms were reported during AXOS-bread intake.
CONCLUSIONS:
AXOS-breads led to a potentially beneficial shift in fermentation end products and are well tolerated